Thank you to Prof Tom Foltynie for his time and expertise last night on the topic of repurposing diabetes drugs, including Exenatide, for Parkinson's disease.
It was an excellent presentation and discussion that brings us all up to date with the latest in the trials, including feedback from some of you actually involved in the trials, so thank you all for your contributions.
If you missed this presentation, or just want to watch it again to fully understand the potential of what was discussed, please click on this link to watch the recording.
youtube.com/channel/UCN2A0v...
Please subscribe to our YouTube channel so that you will get automatic updates when new content is added.
Please feel free to share this recording with other PwP Caregivers and PD professionals.
-----------
Professor Tom Foltynie is Professor of Neurology in the Department of Clinical and Movement Neurosciences, UCL Institute of Neurology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He is responsible for Movement disorder patients, particularly Parkinson’s disease (PD) patients undergoing advanced treatments such as Deep Brain Stimulation (DBS), Apomorphine and Duodopa. He is chief investigator for a series of trials of Exenatide- a potential neurorestorative treatment for PD, as well as the lead clinician at UCL for trials of alpha synuclein vaccination for PD and Oxford Biomedica/ Axovant’s gene therapy product for PD, and the Transeuro PD cell transplantation programme.